Gnomica
1 known investors
Gnomica develops small-molecule drug inhibitors that target bacterial pathways as a treatment for cancer.
BiotechHealthtech
Investors · 1
Frequently asked questions
- What does Gnomica do?
- Gnomica develops small-molecule drug inhibitors that target bacterial pathways as a treatment for cancer.
- Who are Gnomica's investors?
- Gnomica's investors include Chapter One.